Browsing by Author ZHOU ZHIDONG

Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)
2015Association analysis of COQ2 variant in dementia and essential tremorChao Y.X. ; Ng E.Y.L.; Li H. ; Nagaendran K. ; Yih Y. ; Chong M.S.; Prakash K.M. ; Tan L. ; Au W.L. ; Zhao Y.; Zhou Z.D. ; Tio M.; Pavanni R. ; Tan E.K. 
2009Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinonesZhou, Z.D. ; Lim, T.M. 
Feb-2009Dopamine auto-oxidation aggravates non-apoptotic cell death induced by over-expression of human A53T mutant alpha-synuclein in dopaminergic PC12 cellsZhou, Z.D. ; Kerk, S.Y.; Xiong, G.G.; Lim, T.M. 
15-Jan-2006Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant α-synucleinZhou, Z.D. ; Yap, B.P.; Gung, A.Y.T.; Leong, S.M. ; Ang, S.T.; Lim, T.M. 
May-2008Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132Zhou, Z. ; Kerk, S.; Meng Lim, T. 
2017Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (Molecular Neurobiology, (2017), 54, 7, (5534-5546), 10.1007/s12035-016-0099-5)Zhou Z.-D. ; Saw W.-T.; Tan E.-K. 
2015F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagyZhou Z.D. ; Xie S.P.; Sathiyamoorthy S.; Saw W.T.; Sing T.Y.; Ng S.H.; Chua H.P.H.; Tang A.M.Y.; Shaffra F.; Li Z.; Wang H.; Ho P.G.H.; Lai M.K.P. ; Angeles D.C. ; Lim T.M.; Tan E.-K. 
Nov-2010Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugatesZhou, Z.D. ; Lim, T.M. 
2017Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's DiseaseQiu L. ; Liao M.-C.; Chen A.K.; Wei S.; Xie S. ; Reuveny S.; Zhou Z.D. ; Hunziker W. ; Tan E.K. ; Oh S.K.W. ; Zeng L. 
2017Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseasesZhou Z.D. ; Tan E.-K. 
15-Dec-2010Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degenerationZhou, Z.D. ; Lan, Y.H.; Tan, E.K. ; Lim, T.M. 
2017LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stressChen Z. ; Cao Z.; Zhang W.; Gu M. ; Zhou Z.D. ; Li B.; Li J.; Tan E.K. ; Zeng L. 
2017Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative DiseasesZhou Z.-D. ; Saw W.-T.; Tan E.-K. 
Mar-2014Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neuronsZhou, Z.D. ; Refai, F.S.; Xie, S.P.; Ng, S.H.; Chan, C.H.S.; Ho, P.G.H.; Zhang, X.D.; Lim, T.M. ; Tan, E.K. 
2017Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's diseaseChen Z.-C. ; Zhang W.; Chua L.-L. ; Chai C. ; Li R.; Lin L.; Cao Z.; Angeles D.C. ; Stanton L.W. ; Peng J.-H.; Zhou Z.-D. ; Lim K.-L. ; Zeng L. ; Tan E.-K. 
2016Plasma coenzyme Q10 levels and multiple system atrophyChao Y.X. ; Zhou Z. ; Tan E.-K. 
Feb-2009Roles of glutathione (GSH) in dopamine (DA) oxidation studied by improved tandem HPLC plus ESI-MSZhou, Z.D. ; Lim, T.M. 
2017Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variantsTio M. ; Wen R.; Lim Y.L.; Zukifli Z.H.B.; Xie S. ; Ho P.; Zhou Z. ; Koh T.-W. ; Zhao Y.; Tan E.-K.